Acute Changes in Glucose Uptake After Treatment: the Effects of Carmustine (BCNU) on Human Glioblastoma Multiforme

Overview

Journal J Neurooncol

Publisher Springer

Date 1993 Jan 1

PMID 8384254

Citations 10

Authors

J M Rozental

J D Cohen

M P Mehta

R L Levine

J M Hanson

R J Nickles

Affiliations

Soon will be listed here.

Abstract

Sequential positron emission tomographic scans with [18F]-2-fluorodeoxyglucose (PET-FDG) were performed on 6 patients with glioblastoma multiforme who were treated with adjuvant BCNU. Scans were acquired before and 24 hours after BCNU. All patients had prior brain irradiation. Ratios between the maximal tumor FDG uptake and the contralateral white matter FDG uptake, the glucose uptake ratio, were determined. Percent changes in the glucose uptake ratio between the baseline scan and the 24 hour post-treatment scan were of prognostic significance. Patients with the largest percent changes in FDG uptake had the shortest survival. In contrast, neither the baseline glucose uptake ratio nor the visual tumor grade accurately predicted length of survival.

Citing Articles

Emerging Therapies for Glioblastoma.

Rios S, Oyervides S, Uribe D, Reyes A, Fanniel V, Vazquez J Cancers (Basel). 2024; 16(8).

PMID: 38672566 PMC: 11048459. DOI: 10.3390/cancers16081485.

Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression.

Patel C, Beinat C, Xie Y, Chang E, Gambhir S Neoplasia. 2020; 23(1):58-67.

PMID: 33221711 PMC: 7689378. DOI: 10.1016/j.neo.2020.11.003.

Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [F]DASA-23.

Beinat C, Patel C, Xie Y, Gambhir S Mol Imaging Biol. 2019; 22(1):124-133.

PMID: 30989436 PMC: 7959514. DOI: 10.1007/s11307-019-01353-2.

Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.

Galban C, Bhojani M, Lee K, Meyer C, Van Dort M, Kuszpit K Clin Cancer Res. 2010; 16(5):1542-52.

PMID: 20160061 PMC: 2843556. DOI: 10.1158/1078-0432.CCR-08-1812.

[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.

Potzi C, Becherer A, Marosi C, Karanikas G, Szabo M, Dudczak R J Neurooncol. 2007; 84(3):305-14.

PMID: 17492401 DOI: 10.1007/s11060-007-9375-6.

References

Rhodes C, Wise R, Gibbs J, Frackowiak R, Hatazawa J, Palmer A . In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol. 1983; 14(6):614-26. DOI: 10.1002/ana.410140604. View

Rozental J, Levine R, Nickles R, Dobkin J, Hanson J . Cerebral diaschisis in patients with malignant glioma. J Neurooncol. 1990; 8(2):153-61. DOI: 10.1007/BF00177839. View

Fukuyama H, Kameyama M, Harada K, Fujimoto N, Kobayashi A, Taki W . Thalamic tumours invading the brain stem produce crossed cerebellar diaschisis demonstrated by PET. J Neurol Neurosurg Psychiatry. 1986; 49(5):524-8. PMC: 1028806. DOI: 10.1136/jnnp.49.5.524. View

DI CHIRO G, Brooks R, Patronas N, Bairamian D, KORNBLITH P, Smith B . Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol. 1984; 15 Suppl:S138-46. DOI: 10.1002/ana.410150727. View

Jones S, Alavi A, Christman D, Montanez I, Wolf A, Reivich M . The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med. 1982; 23(7):613-7. View

Rozental J, Robins H, Finlay J, Healey B, Levin A, STEEVES R . "Eight-drugs-in-one-day" chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer. 1989; 63(12):2475-81. DOI: 10.1002/1097-0142(19890615)63:12<2475::aid-cncr2820631219>3.0.co;2-h. View

Kushner M, Alavi A, Reivich M, Dann R, Burke A, Robinson G . Contralateral cerebellar hypometabolism following cerebral insult: a positron emission tomographic study. Ann Neurol. 1984; 15(5):425-34. DOI: 10.1002/ana.410150505. View

Valk P, Budinger T, Levin V, Silver P, Gutin P, Doyle W . PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg. 1988; 69(6):830-8. DOI: 10.3171/jns.1988.69.6.0830. View

DI CHIRO G, DelaPaz R, Brooks R, Sokoloff L, KORNBLITH P, Smith B . Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology. 1982; 32(12):1323-9. DOI: 10.1212/wnl.32.12.1323. View

10.

Patronas N, DI CHIRO G, Smith B, De La Paz R, Brooks R, Milam H . Depressed cerebellar glucose metabolism in supratentorial tumors. Brain Res. 1984; 291(1):93-101. DOI: 10.1016/0006-8993(84)90654-1. View

11.

DI CHIRO G, Brooks R . PET quantitation: blessing and curse. J Nucl Med. 1988; 29(9):1603-4. View

12.

Loreck D, GALARRAGA J, Van der Feen J, Phang J, Smith B, Cummins C . Regulation of the pentose phosphate pathway in human astrocytes and gliomas. Metab Brain Dis. 1987; 2(1):31-46. DOI: 10.1007/BF00999507. View

13.

Rozental J, Levine R, Nickles R, Dobkin J . Glucose uptake by gliomas after treatment. A positron emission tomographic study. Arch Neurol. 1989; 46(12):1302-7. DOI: 10.1001/archneur.1989.00520480044018. View

14.

Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6):649-55. View

15.

Kim C, Alavi J, Alavi A, Reivich M . New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol. 1991; 10(1):85-91. DOI: 10.1007/BF00151249. View

16.

Steen R . Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. Cancer Res. 1989; 49(15):4075-85. View

17.

Nelson T, Lucignani G, Goochee J, Crane A, Sokoloff L . Invalidity of criticisms of the deoxyglucose method based on alleged glucose-6-phosphatase activity in brain. J Neurochem. 1986; 46(3):905-19. DOI: 10.1111/j.1471-4159.1986.tb13057.x. View

18.

Brooks R, DI CHIRO G, Zukerberg B, Bairamian D, Larson S . Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method. J Nucl Med. 1987; 28(1):53-9. View

19.

Doyle W, Budinger T, Valk P, Levin V, Gutin P . Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr. 1987; 11(4):563-70. DOI: 10.1097/00004728-198707000-00001. View

20.

Nelson J, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N . Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer. 1983; 52(3):550-4. DOI: 10.1002/1097-0142(19830801)52:3<550::aid-cncr2820520327>3.0.co;2-c. View